1. Home
  2. TIRX vs NLSP Comparison

TIRX vs NLSP Comparison

Compare TIRX & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIRX
  • NLSP
  • Stock Information
  • Founded
  • TIRX 2010
  • NLSP 2015
  • Country
  • TIRX China
  • NLSP Switzerland
  • Employees
  • TIRX N/A
  • NLSP N/A
  • Industry
  • TIRX Specialty Insurers
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIRX Finance
  • NLSP Health Care
  • Exchange
  • TIRX Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • TIRX 14.0M
  • NLSP 12.4M
  • IPO Year
  • TIRX 2021
  • NLSP 2021
  • Fundamental
  • Price
  • TIRX $1.26
  • NLSP $2.41
  • Analyst Decision
  • TIRX
  • NLSP
  • Analyst Count
  • TIRX 0
  • NLSP 0
  • Target Price
  • TIRX N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • TIRX 1.2M
  • NLSP 371.7K
  • Earning Date
  • TIRX 08-15-2025
  • NLSP 07-01-2025
  • Dividend Yield
  • TIRX N/A
  • NLSP N/A
  • EPS Growth
  • TIRX N/A
  • NLSP N/A
  • EPS
  • TIRX N/A
  • NLSP N/A
  • Revenue
  • TIRX $3,219,336.00
  • NLSP N/A
  • Revenue This Year
  • TIRX N/A
  • NLSP N/A
  • Revenue Next Year
  • TIRX N/A
  • NLSP N/A
  • P/E Ratio
  • TIRX N/A
  • NLSP N/A
  • Revenue Growth
  • TIRX 158.74
  • NLSP N/A
  • 52 Week Low
  • TIRX $1.07
  • NLSP $1.30
  • 52 Week High
  • TIRX $4.15
  • NLSP $16.00
  • Technical
  • Relative Strength Index (RSI)
  • TIRX 42.23
  • NLSP 60.14
  • Support Level
  • TIRX $1.25
  • NLSP $2.22
  • Resistance Level
  • TIRX $1.45
  • NLSP $2.38
  • Average True Range (ATR)
  • TIRX 0.12
  • NLSP 0.20
  • MACD
  • TIRX -0.02
  • NLSP -0.01
  • Stochastic Oscillator
  • TIRX 2.22
  • NLSP 53.13

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: